A Solution to End-Stage Heart Failure: Total Artificial Hearts
End-stage heart failure remains one of the most pressing challenges in modern medicine, affecting millions worldwide and leaving many patients with limited treatment options. While heart transplantation is considered the gold standard, the persistent shortage of donor organs means that a significant number of patients never receive the life-saving therapy they need. Mechanical circulatory support devices such as ventricular assist devices (VADs) provide partial solutions, but they are not always sufficient for patients whose hearts have irreversibly lost function. In this context, Total Artificial Hearts (TAHs) emerge as a transformative alternative — fully replacing the native heart and restoring circulatory function.
